The p38 pathway: from biology to cancer therapy

A Martínez-Limón, M Joaquin, M Caballero… - International journal of …, 2020 - mdpi.com
The p38 MAPK pathway is well known for its role in transducing stress signals from the
environment. Many key players and regulatory mechanisms of this signaling cascade have …

Control of cell cycle transcription during G1 and S phases

C Bertoli, JM Skotheim, RAM De Bruin - Nature reviews Molecular cell …, 2013 - nature.com
The accurate transition from G1 phase of the cell cycle to S phase is crucial for the control of
eukaryotic cell proliferation, and its misregulation promotes oncogenesis. During G1 phase …

Towards precision oncology in advanced prostate cancer

SY Ku, ME Gleave, H Beltran - Nature Reviews Urology, 2019 - nature.com
Metastatic biopsy programmes combined with advances in genomic sequencing have
provided new insights into the molecular landscape of castration-resistant prostate cancer …

The blood-testis barrier and its implications for male contraception

CY Cheng, DD Mruk, DR Sibley - Pharmacological reviews, 2012 - Elsevier
The blood-testis barrier (BTB) is one of the tightest blood-tissue barriers in the mammalian
body. It divides the seminiferous epithelium into the basal and the apical (adluminal) …

Targeting epigenetics for cancer therapy

JW Park, JW Han - Archives of pharmacal research, 2019 - Springer
Cancer can be identified as a chaotic cell state, which breaks the rules that govern growth
and reproduction, with main characteristics such as uncontrolled division, invading other …

The nucleolus: an emerging target for cancer therapy

N Hein, KM Hannan, AJ George, E Sanij… - Trends in molecular …, 2013 - cell.com
For over 100 years, pathologists have utilised an increase in size and number of nucleoli,
the subnuclear site of ribosome synthesis, as a marker of aggressive tumours. Despite this …

Telomerase and hallmarks of cancer: an intricate interplay governing cancer cell evolution

G Sethi - Cancer letters, 2023 - Elsevier
Transformed cells must acquire specific characteristics to be malignant. Weinberg and
Hanahan characterize these characteristics as cancer hallmarks. Though these features are …

Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis

MS Kareta, LL Gorges, S Hafeez, BA Benayoun… - Cell stem cell, 2015 - cell.com
Mutations in the retinoblastoma tumor suppressor gene Rb are involved in many forms of
human cancer. In this study, we investigated the early consequences of inactivating Rb in …

The retinoblastoma (RB) tumor suppressor: pushing back against genome instability on multiple fronts

R Vélez-Cruz, DG Johnson - International journal of molecular sciences, 2017 - mdpi.com
The retinoblastoma (RB) tumor suppressor is known as a master regulator of the cell cycle.
RB is mutated or functionally inactivated in the majority of human cancers. This …

FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and …

I Wierstra - Advances in cancer research, 2013 - Elsevier
Abstract FOXM1 (Forkhead box M1) is a typical proliferation-associated transcription factor
and is also intimately involved in tumorigenesis. FOXM1 stimulates cell proliferation and cell …